Nadine Al-Naamani, MD, MS
Pulmonary Medicine
Accepting new patients
Sees patients age 18 and up
Harron Lung Center University City
Headshot of Nadine Al-Naamani, MD, MS
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Lebanese University
  • Residency: Mount Sinai Morningside
  • Residency: The Cambridge Hospital
  • Fellowship: Tufts - New England Medical Center

What my patients think about me

Average Rating

97 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

February 2026
dr was patient and informative
December 2025
because of my positive experience with Dr. Al-Naamani i would positively recommend her.
November 2025
care, understanding, looking for all possibilities
November 2025
md obviously ahead of those i've seen previously in clinical expertise and ability to communicate the physiology related to my problem.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Al-Naamani is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

G.J. Farley, M.R. Anderson, J.S. Fritz, S.M. Kawut, J. Minhas, A. Smith, H.I. Palevsky, S.C. Pugliese, D.A. Torigian, Y. Tong, J.K. Udupa, J.F. Baker, C.E. Ventetuolo, N. Al-Naamani Losing Strength, Slice by Slice: Diagnosing Sarcopenia via Chest CT in Pulmonary Arterial Hypertension (PAH) , American Thoracic Society International Conference, Orlando FL,: 2026


A. Gayner, R.P. Frantz, P.M. Hassoun, E. Horn, J. Leopold, F.P. Rischard, E.B. Rosenzweig, N.S. Hill, S.C. Erzurum, A. Hemnes, N. Al-Naamani Quality Of Life In Pulmonary Arterial Hypertension: A Comparative Analysis Of Patients With Insulin Resistance Versus Insulin Sensitivity , American Thoracic Society International Conference, Orlando FL,: 2026


Y. Zou, N. Al-Naamani, J. Moutchia, M.J. Krowka, M.B. Fallon, S.M. Kawut, J. Minhas Beta-Blocker Use Is Associated With Longer 6-Minute Walk Distance in Hepatopulmonary Syndrome and Portopulmonary Hypertension Compared to Liver Disease Controls , American Thoracic Society International Conference, Orlando FL,: 2026


B. E. McCarthy, R. Feng, J.S. Moutchia, R. Urbanowicz, J. H. Holmes, S.M. Kawut, N. Al-Naamani Heterogeneity of Treatment-Associated Adverse Events in Pulmonary Arterial Hypertension: An Individual Participant Data Meta-Analysis , American Thoracic Society International Conference, Orlando FL,: 2026


Minhas J, Shou H, Al-Naamani N, Feng R, Zamanian R, Bull T, Chakinala M, Hemnes A, Moutchia J, Mathai SC, Ellenberg S, Ventetuolo C, Kawut SM. Daily Physical Activity in Pulmonary Arterial Hypertension: Insights from a Multicenter Longitudinal Trial Using Accelerometry , Chest: 2026


Huang X, Balasubramanian A, Moutchia J, Williams K, Al-Naamani N, Batson M, Gassett AJ, Minhas J, Kaufman JD, Leary PJ, McCormack MC, Mathai SC, Kawut SM, Sack C Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry , Ann Am Thorac Soc, 22(9): 2025,1351-1360


Sridhar M, Tauquir A, Sahay S, Tonelli AR, Al-Naamani N, and Cajigas HR Frailty in Pulmonary Hypertension: A Multidimensional Comorbidity , Ann Am Thorac Soc, 22(8): 2025,1115-1125


Meservey A, Al-Naamani N, Minhas J, Fritz JS, Appleby D, Baudry G, Girerd N, Feng R, Kawut SM, Moutchia J. Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis , Eur Respir J, 66(2): 2025,2402400


Minhas, JK, Al-Naamani, N Treprostinil in Pulmonary Arterial Hypertension With Cardiovascular Comorbidities: To Use or Avoid , Chest, 167(6): 2025,1532-1534


B.E. McCarthy, R. Feng, R. Bernardo, O. Shlobin, T. De Marco, T. Wichman, K.W. Presberg, A. Ravichandran, E. Horn, J.M. Elwing, M.P. George, J.R. Runo, Z. Safdar, C.E. Ventetuolo, N. Al-Naamani Impact of Insurance Type on Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry , American Thoracic Society International Conference, San Francisco CA: 2025


View all publications